IVUS-XPL: IVUS superior to angiography for guiding DES implantation in long lesions

Original Title: Effect of intravascular ultrasound-guided vs angiography-guided everolimus-eluting stent implantation: the IVUS-XPL randomized clinical trial. Presenter: Hong S-J.

Patients with long coronary lesions have better clinical results after a year of second generation DES implantation when interventions are guided by IVUS, instead of angiography. The benefit was attributed to a lower revascularization rate of ischemia driven target lesions. For the trial, carried out in 20 Korean centers, researchers included 1,400 patients (mean age 64; 69% male) with chest pain or evidence of myocardial ischemia and diffuse long coronary lesions (visually estimatedstent length of  ≥ 28 mm). All patients received the Xience Prime stent (Abbott Vascular) and dual ATP with aspirin and clopidogrel through6 months or more.

In patients randomized to IVUS guided stent implantation online IVUS measurements were used to select stent size and length; adjunct high-pressure dilation was performed at the discretion of the physicians based on IVUS findings.Physicians could perform IVUS at any step of PCI, but IVUS exam was mandatory after PCI.

The average stent length was 39.3 mm. During procedure, patients in the IVUS arm more frequently received adjunct post-dilation (76% vs 57%) and had a larger mean final balloon size (3.14 vs 3.04 mm; P <0.001 for both). As a result, patients who underwent IVUS-guided procedure had a higher minimum lumen diameter (2.64 vs 2.56 mm; P <0.001) and lower diameter stenosis (12.79% vs 13.74%; P = .04) on post-intervention quantitative coronary angiography.

Patients in the IVUS arm required ischemia driven target lesion revascularization 2.5% of times vs. 5% in the control group.

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...